Cargando…
Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease
The prevalence of rheumatic heart disease (RHD) in the Aboriginal population of the Australian Northern Territory is high, and Streptococcus pyogenes skin infections likely contribute to this. A promising candidate S. pyogenes “30mer” vaccine is composed of 30 pharyngitis associated type-specific an...
Autores principales: | Giffard, Philip M., Tong, Steven Y. C., Holt, Deborah C., Ralph, Anna P., Currie, Bart J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6634427/ https://www.ncbi.nlm.nih.gov/pubmed/31269021 http://dx.doi.org/10.1371/journal.pntd.0007511 |
Ejemplares similares
-
Therapeutics for rheumatic fever and rheumatic heart disease
por: Ralph, Anna P, et al.
Publicado: (2022) -
Extensive Diversity of Streptococcus pyogenes in a Remote Human Population Reflects Global-Scale Transmission Rather than Localised Diversification
por: Towers, Rebecca J., et al.
Publicado: (2013) -
Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model
por: Reynolds, Simone, et al.
Publicado: (2023) -
Streptococcus pyogenes balanoposthitis
por: Norimatsu, Yuta, et al.
Publicado: (2020) -
The Streptococcus pyogenes vaccine landscape
por: Walkinshaw, Donald R., et al.
Publicado: (2023)